Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

24 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Allo-HLA-reactive T cells inducing graft-versus-host disease are single peptide specific.
Amir AL, van der Steen DM, Hagedoorn RS, Kester MG, van Bergen CA, Drijfhout JW, de Ru AH, Falkenburg JH, van Veelen PA, Heemskerk MH. Amir AL, et al. Among authors: van veelen pa, van der steen dm, van bergen ca. Blood. 2011 Dec 22;118(26):6733-42. doi: 10.1182/blood-2011-05-354787. Epub 2011 Oct 4. Blood. 2011. PMID: 21972290 Free article.
Identification of varicella-zoster virus-specific CD8 T cells in patients after T-cell-depleted allogeneic stem cell transplantation.
van der Heiden PL, de Boer R, van der Steen DM, Kester MG, van der Hoorn MW, Haarman WM, Barnby-Porritt HE, Fry JW, Napper CE, Marijt EW, Willemze R, Falkenburg JH, Heemskerk MH. van der Heiden PL, et al. Among authors: van der steen dm, van der hoorn mw. J Virol. 2009 Jul;83(14):7361-4. doi: 10.1128/JVI.02662-08. Epub 2009 Apr 22. J Virol. 2009. PMID: 19386715 Free PMC article.
Combined CD8+ and CD4+ adenovirus hexon-specific T cells associated with viral clearance after stem cell transplantation as treatment for adenovirus infection.
Zandvliet ML, Falkenburg JH, van Liempt E, Veltrop-Duits LA, Lankester AC, Kalpoe JS, Kester MG, van der Steen DM, van Tol MJ, Willemze R, Guchelaar HJ, Schilham MW, Meij P. Zandvliet ML, et al. Among authors: van tol mj, van liempt e, van der steen dm. Haematologica. 2010 Nov;95(11):1943-51. doi: 10.3324/haematol.2010.022947. Epub 2010 Jun 18. Haematologica. 2010. PMID: 20562315 Free PMC article. Clinical Trial.
PRAME-specific Allo-HLA-restricted T cells with potent antitumor reactivity useful for therapeutic T-cell receptor gene transfer.
Amir AL, van der Steen DM, van Loenen MM, Hagedoorn RS, de Boer R, Kester MD, de Ru AH, Lugthart GJ, van Kooten C, Hiemstra PS, Jedema I, Griffioen M, van Veelen PA, Falkenburg JH, Heemskerk MH. Amir AL, et al. Among authors: van kooten c, van veelen pa, van der steen dm, van loenen mm. Clin Cancer Res. 2011 Sep 1;17(17):5615-25. doi: 10.1158/1078-0432.CCR-11-1066. Epub 2011 Jul 19. Clin Cancer Res. 2011. PMID: 21771875
HLA monomers as a tool to monitor indirect allorecognition.
Breman E, van Miert PP, van der Steen DM, Heemskerk MH, Doxiadis II, Roelen D, Claas FH, van Kooten C. Breman E, et al. Among authors: van kooten c, van miert pp, van der steen dm. Transplantation. 2014 Jun 15;97(11):1119-27. doi: 10.1097/TP.0000000000000113. Transplantation. 2014. PMID: 24798312 Free PMC article.
TCR-based therapy for multiple myeloma and other B-cell malignancies targeting intracellular transcription factor BOB1.
Jahn L, Hombrink P, Hagedoorn RS, Kester MG, van der Steen DM, Rodriguez T, Pentcheva-Hoang T, de Ru AH, Schoonakker MP, Meeuwsen MH, Griffioen M, van Veelen PA, Falkenburg JH, Heemskerk MH. Jahn L, et al. Among authors: van veelen pa, van der steen dm. Blood. 2017 Mar 9;129(10):1284-1295. doi: 10.1182/blood-2016-09-737536. Epub 2017 Jan 4. Blood. 2017. PMID: 28053195 Free article.
24 results